IMUN - Immune Therapeutics, Inc.
| Previous Close | 0.0295 |
| Open | 0.0295 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0280 - 0.0349 |
| 52 Week Range | 0.0100 - 0.0900 |
| Volume | 185,598 |
| Avg. Volume | 1,342,492 |
| Market Cap | 11.656M |
| Beta | 1.27 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0230 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- GlobeNewswire•28 days ago
Immune Therapeutics, Inc. Received Minutes From FDA Meeting for Lodonal™ for the Treatment for Crohn’s Disease
ORLANDO, Fla., March 26, 2018-- via OTC PR WIRE-- Immune Therapeutics, Inc., a clinical late stage biopharmaceutical company focused on the development of two immunomodulating therapies for the treatment ...
- GlobeNewswire•2 months ago
Immune Therapeutics, Inc. Announces First Sales & Shipment of Lodonal; Receives Trademark and Patent Approval From Federal Republic of Nigeria
ORLANDO, Fla., Feb. 20, 2018-- via OTC PR WIRE-- Immune Therapeutics, Inc., a clinical late stage biopharmaceutical company focused on the development of two immunomodulating therapies for the treatment ...
- PR Newswire•5 months ago
Immune Therapeutics, Inc. Shareholder Update Letter
The lack of revenue from Nigeria after obtaining approval has been major concern to shareholders and also to the company. The company's distribution agreement is being modified which caused a delay in shipping product and realization of revenue.
- PR Newswire•8 months ago
Immune Therapeutics, Inc. Announces Exclusive Agreement For Sale Of Lodonal In Kenya Valued At Over $31 Million
Omaera will supply Lodonal to patients exclusively in Kenya, where 5.9% of the country's 47 million population live with HIV/AIDS. Omaera Territory includes six countries: Republic of Kenya, Republic of Uganda United Republic of Tanzania, Republic of Burundi and Republic of Rwanda. Omaera was launched in 1993 as a locally owned wholesaling operation that has grown into one of the most recognized medical supply and distribution companies in East Africa.
- Accesswire•11 months ago
Immune Therapeutics to Present at the 7th Annual LD Micro Invitational
LOS ANGELES, CA / ACCESSWIRE / June 5, 2017 / Immune Therapeutics, Inc. (OTCQB: IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic ...